Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

TauRx’s HMTM could become first oral DMT targeting Tau for Alzheimer’s disease, says GlobalData

Following the Phase III LUCIDITY trial (NCT03446001) results announced by TauRx at the AD/PD 2024 International Conference on Alzheimer’s and Parkinson’s Diseases, for hydromethylthionine mesylate (HMTM); Philippa Salter, Senior Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “At AD/PD 2024, TauRx announced that it has initiated regulatory discussions with both […]
Read more

Illinois faces staggering economic costs of $17.6 billion due to obesity, reveals GlobalData

Obesity and overweight are estimated to have caused a staggering $17.6 billion reduction in Illinois’ economy in 2022, equivalent to 1.7% of the state’s gross domestic product (GDP), according to a report released by GlobalData Plc, a leading data and analytics company. GlobalData’s report, ‘Obesity’s Impact on Illinois’ Economy and Labor Force,’ analyzes the economic […]
Read more

Growth, expansion, and late-stage VC funding rounds fell by 36.5% in 2023, while early-stage funding rounds declined by 27.9%, finds GlobalData

A total of 2,326 growth, expansion, and late-stage venture capital (VC) funding rounds (Series B onwards) were announced globally during 2023, which is a decline of 36.5% over the announcement of 3,665 growth, expansion, and late-stage VC funding rounds in 2022. Meanwhile, a total of 9,273 early-stage VC funding rounds (comprising Seed and Series A […]
Read more

China to dominate global PET capacity additions through 2028, forecasts GlobalData

China is set to register the highest polyethylene terephthalate (PET) capacity additions globally by 2028, contributing about 40% of the total capacity additions from new plant and expansion projects, says GlobalData, a leading data and analytics company. GlobalData’s latest report, “Polyethylene Terephthalate (PET) Industry Capacity and Capital Expenditure Forecasts with Details of All Active and […]
Read more

Deteriorating global security environment to spur US defense expenditure to $931.6 billion in 2028, forecasts GlobalData

The US aims to improve military readiness and strengthen deterrence in an era defined by rising aggression from authoritarian governments and non-state actors. Faced with growing concerns about the stability of the rules-based international order, the US is forecasted to further increase defense spending to $931.6 billion in 2028, up from $818.8 billion in 2023, […]
Read more

Biogen needs Leqembi to be successful following discontinuation of Aduhelm, says GlobalData

Biogen’s stance at the upcoming AD/PD 2024 International Conference on Alzheimer’s disease (AD) and Parkinson’s disease (PD) that will be held on March 5-9 will demonstrate its future plans for AD following the discontinuation of Aduhelm (aducanumab), its anti-amyloid beta (Aβ) monoclonal antibody (mAb). Against this backdrop, the success of Leqembi (lecanemab) remains important for […]
Read more

Nezglyal remains promising therapy despite EMA’s market authorization refusal, says GlobalData

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recently recommended the refusal of the marketing authorization for Nezglyal (leriglitazone). Nezglyal is a novel orally bioavailable and selective peroxisome proliferator-activated receptor (PPAR) gamma agonist that is intended for the treatment of cerebral adrenoleukodystrophy (cALD). Leriglitazone is a promising treatment that can […]
Read more

India to lead global ethylene glycol capacity additions through 2028, forecasts GlobalData

India is set to register the highest ethylene glycol capacity additions globally by 2028, contributing about 25% of the total capacity additions from new plant and expansion projects, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Ethylene Glycol Industry Capacity and Capital Expenditure Forecasts with Details of All Active and Planned […]
Read more

Allecra’s EXBLIFEP approval to treat cUTIs provides valuable new weapon to tackle ESBL mediated AMR, says GlobalData

The FDA has approved Allecra Therapeutics’ novel antibiotic combination, EXBLIFEP (cefepime/enmetazobactam), to treat complicated urinary tract infections (cUTIs), including acute pyelonephritis (AP), in patients ≥ 18 years of age caused by the following gram-negative bacteria: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, and Enterobacter cloacae complex. Designed as a “carbapenem-sparing” treatment for multi-drug resistant […]
Read more

Apple’s shift from EVs to AI sparks diverse reactions among influencers, reveals GlobalData

With reports emerging on Apple’s plans to shelve its electric vehicle (EV) project, a subsequent rise in discussions related to “Apple” among the influencers on “X” platform has been witnessed in the last week of February, according to the Social Media Analytics Platform of GlobalData, a leading data and analytics company. Smitarani Tripathy, Social Media […]
Read more
1 … 84 85 86 87 88 … 136